Table 2.
Multivariate Logistic Regression of SARS-CoV-2 Serum IgG Positivity by NAAT Result, for Simultaneous IgG and NAAT Testing
Predictor | Odds ratio estimates (95% confidence limits) |
P |
---|---|---|
NAAT Positive (n = 3868) | ||
State (NY/NJ/MA/RI/CT vs Other States) | 10.3 (8.8, 12.0) | <.0001 |
Age in years (≥35 vs 2–34) | 1.7 (1.4, 2.0) | <.0001 |
Sex (M vs F) | 1.1 (0.9, 1.3) | .4 |
CCI* (≥1 vs None) | 1.5 (1.3, 1.8) | <.0001 |
NAAT Negative (n = 186,301) | ||
State (NY/NJ/MA/RI/CT vs Other States) | 6.8 (6.4, 7.2) | <.0001 |
Age in years (≥35 vs 2–34) | 1.1 (1.1, 1.2) | <.0001 |
Sex (M vs F) | 1.0 (1.0, 1.1) | .007 |
CCI* (≥1 vs None) | 1.2 (1.2, 1.3) | <.0001 |
Logistic regression modeling IgG positive versus IgG negative with all predictors in the model, stratified by NAAT result.
Compare ≥1 CCI vs. no CCI.
CCI, chronic condition indicator; IgG, immunoglobulin G; NAAT, nucleic acid amplification testing; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2.